Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Democrats swept the 2026 midterms and now hold the keys to reshaping federal health policy — but turning election wins into legislative wins is a whole different game. Their top priorities include restoring ACA subsidies, reversing Medicaid cuts, and launching oversight investigations into the Trump administration's health agenda. The road ahead is steep, with Trump's veto pen and a $1.2 trillion funding gap standing in the way.
Democrats' decisive sweep of the 2026 midterm elections — projected to win at least 237 House seats and 54 Senate seats — has set the stage for a major reshuffling of federal health policy. Voters consistently ranked healthcare affordability as a top concern, and Democrats are now positioned to argue they have a clear mandate to act. Their early agenda is expected to include restoring enhanced ACA premium subsidies (which lapsed after Republicans declined to extend them), reversing Medicaid cuts from the One Big Beautiful Bill Act, and launching oversight investigations into HHS Secretary RFK Jr.'s tenure.
But translating electoral momentum into actual policy is easier said than done. Trump retains veto power, and undoing the Medicaid and ACA cuts would require finding roughly $1.2 trillion in offsets over 10 years — a tall order that demands consensus Democrats don't yet have. The lame-duck session through year-end is expected to deliver little beyond government funding basics, with the real legislative battles kicking off in January 2027.
Key Takeaways:
Why it matters: The 2026 midterms may have flipped Congress, but the real test is whether Democrats can deliver tangible healthcare wins — on affordability, Medicaid, and public health infrastructure — before 2028. Failure to act could hand voters another reason for frustration, regardless of party.
